Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pancreatic Ductal Adenocarcinoma (PDAC) × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 7 Neoplasm Metastasis 2 Adenocarcinoma 2 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplasms 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Gastroesophageal Adenocarcinoma 1 Carcinoma 1

Interventions

folfirinox 1 Taxes 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02782182 2019-03-19

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

University of Chicago

Phase 1 Terminated

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡